» Articles » PMID: 17929308

Growth Failure and Outcomes in Infants with Biliary Atresia: a Report from the Biliary Atresia Research Consortium

Abstract

Unlabelled: Malnutrition is a significant clinical problem in infants with biliary atresia. The natural history of poor growth and its potential association with early transplantation or death in children with biliary atresia was determined. Serial weight- and length-for-age z-scores were computed as part of a retrospective study of 100 infants who underwent hepatoportoenterostomy (HPE) for biliary atresia at 9 U.S. pediatric centers between 1997 and 2000. Poor outcome was defined as transplantation or death by 24 months of age (n = 46) and good outcome was defined as survival with native liver at 24 months of age with total serum bilirubin less than 6 mg/dL (n = 54). Growth velocity was significantly slower in the poor outcome group compared to the good outcome group (P < 0.001 for both weight and length). Mean weight z-scores were significantly lower by 6 months after HPE in the poor outcome group (-2.1 +/- 1.4) compared to the good outcome group (-1.2 +/- 1.4) (P < 0.001). In a subgroup with total bilirubin between 2 and 6 mg/dL at 3 months after HPE (n = 28), the weight z-scores at 3 months after HPE were significantly lower in the poor outcome group (-2.0 +/-1.2) compared to the good outcome group (-1.0 +/- 1.2) (P = 0.04) despite similar bilirubin concentrations.

Conclusion: Growth failure after HPE was associated with transplantation or death by 24 months of age. The combination of intermediate bilirubin concentrations and poor mean weight z-scores 3 months after HPE was also associated with poor clinical outcome.

Citing Articles

The association of human milk intake and outcomes in biliary atresia.

Tessier M, Schraw J, Beer S, Harpavat S, Jensen M, Magee J J Pediatr Gastroenterol Nutr. 2024; 80(1):163-173.

PMID: 39526563 PMC: 11863988. DOI: 10.1002/jpn3.12403.


Early life growth and developmental trajectory in children with biliary atresia undergoing primary liver transplantation.

Fang H, Li Z, Xian R, Yin Y, Wang J, Guo H Front Pediatr. 2023; 11:1198360.

PMID: 37377760 PMC: 10291188. DOI: 10.3389/fped.2023.1198360.


Current and emerging adjuvant therapies in biliary atresia.

Fligor S, Hirsch T, Tsikis S, Adeola A, Puder M Front Pediatr. 2022; 10:1007813.

PMID: 36313875 PMC: 9614654. DOI: 10.3389/fped.2022.1007813.


Efficacy and tolerance of enteral nutrition in children with biliary atresia awaiting liver transplantation.

Privat E, Aumar M, Ley D, Tran L, Coopman S, Guimber D Front Pediatr. 2022; 10:983717.

PMID: 36120654 PMC: 9479203. DOI: 10.3389/fped.2022.983717.


Biliary Atresia in Children: Update on Disease Mechanism, Therapies, and Patient Outcomes.

Antala S, Taylor S Clin Liver Dis. 2022; 26(3):341-354.

PMID: 35868678 PMC: 9309872. DOI: 10.1016/j.cld.2022.03.001.


References
1.
Holt R, Miell J, Jones J, Mieli-Vergani G, Baker A . Nasogastric feeding enhances nutritional status in paediatric liver disease but does not alter circulating levels of IGF-I and IGF binding proteins. Clin Endocrinol (Oxf). 2000; 52(2):217-24. DOI: 10.1046/j.1365-2265.2000.00934.x. View

2.
Shneider B, Brown M, Haber B, Whitington P, Schwarz K, Squires R . A multicenter study of the outcome of biliary atresia in the United States, 1997 to 2000. J Pediatr. 2006; 148(4):467-474. DOI: 10.1016/j.jpeds.2005.12.054. View

3.
Ohhama Y, Shinkai M, Fujita S, Nishi T, Yamamoto H . Early prediction of long-term survival and the timing of liver transplantation after the Kasai operation. J Pediatr Surg. 2000; 35(7):1031-4. DOI: 10.1053/jpsu.2000.7765. View

4.
Sokol R, Stall C . Anthropometric evaluation of children with chronic liver disease. Am J Clin Nutr. 1990; 52(2):203-8. DOI: 10.1093/ajcn/52.2.203. View

5.
Sokol R, Mack C, Narkewicz M, Karrer F . Pathogenesis and outcome of biliary atresia: current concepts. J Pediatr Gastroenterol Nutr. 2003; 37(1):4-21. DOI: 10.1097/00005176-200307000-00003. View